Good spot re GCDD0039: they're presumably awaiting assay results.
I'm not surprised about their decision on Kaskara. The analyst reports released at the turn of the year made little mention of it. It's something to return to. They're conserving the cash for the near surface exploration at Guchab and Schlangental and that makes perfect sense.
- Forums
- ASX - By Stock
- SBR
- Ann: Quarterly Cashflow Report
Ann: Quarterly Cashflow Report , page-7
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SBR (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.894M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 634370 | 1.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.5¢ | 497500 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 634370 | 0.013 |
5 | 460310 | 0.012 |
2 | 408999 | 0.011 |
2 | 150000 | 0.010 |
2 | 495000 | 0.008 |
Price($) | Vol. | No. |
---|---|---|
0.015 | 497500 | 2 |
0.018 | 187001 | 1 |
0.019 | 370000 | 3 |
0.020 | 311324 | 4 |
0.021 | 57008 | 1 |
Last trade - 16.12pm 10/10/2024 (20 minute delay) ? |
Featured News
SBR (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online